Oligonucleotide Uptake and Delivery in Tissue Culture Cells

[1]  H. Gamper,et al.  Triplex targeting of a native gene in permeabilized intact cells: covalent modification of the gene for the chemokine receptor CCR5. , 1998, Nucleic acids research.

[2]  C. Delporte,et al.  Triplex-forming oligonucleotides can modulate aquaporin-5 gene expression in epithelial cells. , 1997, Antisense & nucleic acid drug development.

[3]  C. Giovannangeli,et al.  Progress in developments of triplex-based strategies. , 1997, Antisense & nucleic acid drug development.

[4]  C. Stein.  Controversies in the cellular pharmacology of oligodeoxynucleotides. , 1997, Antisense & nucleic acid drug development.

[5]  C. Giovannangeli,et al.  Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Harel-Bellan,et al.  Detection of covalent triplex within human cells. , 1996, Nucleic acids research.

[7]  J. Madon,et al.  Receptor‐mediated delivery of hepatitis B virus DNA and antisense oligodeoxynucleotides to avian liver cells , 1996, Hepatology.

[8]  C. Miller,et al.  Efficient delivery of triplex forming oligonucleotides to tumor cells by adenovirus-polylysine complexes. , 1996, Gene therapy.

[9]  P. Glazer,et al.  Mutagenesis in Mammalian Cells Induced by Triple Helix Formation and Transcription-Coupled Repair , 1996, Science.

[10]  L. Israël,et al.  Temporary ex vivo inhibition of the expression of the human oncogene HER2 (NEU) by a triple helix-forming oligonucleotide. , 1996, Cancer research.

[11]  C. Malvy,et al.  Investigation of the intracellular stability and formation of a triple helix formed with a short purine oligonucleotide targeted to the murine c-pim-1 proto-oncogene promotor. , 1996, Nucleic acids research.

[12]  L. Aurelian,et al.  Antiviral activity of an oligo(nucleoside methylphosphonate) that targets HSV-1 immediate-early pre-mRNA 4,5 is augmented by cotreatment with replication-defective adenovirus. , 1995, Antisense research and development.

[13]  Curiel Dt,et al.  Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. , 1994, Gene therapy.

[14]  B. Wold,et al.  Phosphorothioate oligonucleotide-directed triple helix formation. , 1994, Biochemistry.

[15]  D. Curiel.  High‐Efficiency Gene Transfer Mediated by Adenovirus‐Polylysine‐DNA Complexes , 1994 .

[16]  S. Agrawal,et al.  Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. , 1994, Antisense research and development.

[17]  J. E. Gee,et al.  Triplex formation inhibits HER-2/neu transcription in vitro. , 1993, The Journal of clinical investigation.

[18]  C. Hunt,et al.  Characteristics of oligonucleotide uptake in human keratinocyte cultures. , 1993, The Journal of investigative dermatology.

[19]  R. Wagner,et al.  Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. , 1993, Nucleic acids research.

[20]  A. Murakami,et al.  Interaction of antisense DNA with nucleic acids/proteins. , 1992, Nucleic acids symposium series.

[21]  G. Zon,et al.  Duplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers. , 1991, Nucleic acids research.